Nomura Asset Management International’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.2M Buy
47,407
+74
+0.2% +$14.2K 0.02% 745
2026
Q1
$8.68M Buy
47,333
+993
+2% +$183K 0.01% 707
2025
Q4
$8.15M Buy
+46,340
New +$7.57M 0.01% 733

Other funds holding BIIB

Nomura Asset Management International's BIIB Position: Q2 2026 in Review

Nomura Asset Management International increased its Biogen (BIIB) stake by 0.16% in Q2 2026, buying an estimated $14.2K and bringing the position to 47,407 shares worth $10.2M. The position accounts for 0.02% of the portfolio, ranked #745.

Nomura Asset Management International first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Nomura Asset Management International held 47,407 shares of Biogen worth $10.2M as of Q2 2026.
  • Nomura Asset Management International bought 74 Biogen shares in Q2 2026, an estimated $14.2K.
  • Biogen made up 0.02% of Nomura Asset Management International's portfolio in Q2 2026, its #745 holding.
  • Nomura Asset Management International first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.